What is the appropriate treatment for hyperchloremia with a serum chloride level of 116 mEq/L?

Treatment for Chloride 116 mEq/L

For hyperchloremia at 116 mEq/L, immediately discontinue 0.9% saline and switch to buffered crystalloid solutions (Ringer's Lactate or Plasmalyte), as this level is associated with increased mortality and acute kidney injury risk in critically ill patients.

Immediate Management Algorithm

Step 1: Stop Chloride-Rich Solutions

• Discontinue all 0.9% saline infusions immediately 1, 2
• Switch to buffered crystalloid solutions (Ringer's Lactate or Plasmalyte) for all ongoing fluid needs
• This is a strong recommendation based on high-quality evidence showing that buffered solutions reduce major adverse kidney events and mortality 1

Step 2: Assess Clinical Context and Severity

Your chloride of 116 mEq/L represents moderate hyperchloremia (normal range: 98-107 mEq/L). The clinical significance depends on:

• Check arterial blood gas: Look for hyperchloremic metabolic acidosis (low pH, low bicarbonate, normal anion gap)
• Assess renal function: Hyperchloremia at this level increases AKI risk by 40% 3
• Review fluid balance: Large-volume 0.9% saline administration (>5000 mL) is the most common iatrogenic cause 2

Step 3: Specific Treatment Based on Clinical Scenario

If metabolic acidosis is present (pH <7.35):

• Consider sodium bicarbonate therapy, as hyperchloremic metabolic acidosis specifically benefits from bicarbonate treatment 4
• Recent 2025 data shows patients with high chloride (≥112 mmol/L) and metabolic acidosis have improved survival with bicarbonate therapy 4
• Monitor for complications: hypernatremia, hypokalemia, hypocalcemia

If severe/refractory hyperchloremia (>165 mEq/L) with acidosis:

• Consider early hemodialysis (within 4 hours) for cases unresponsive to conservative management 5
• This is particularly relevant if corrosive ingestion or toxic exposure is suspected

For ongoing fluid requirements:

• Use only buffered crystalloids (Ringer's Lactate or Plasmalyte) 1, 2
• Avoid all chloride-rich solutions including 0.9% saline and hypertonic saline 1

Critical Evidence Points

The 2024 perioperative fluid management guidelines provide the strongest evidence: administration of large volumes of 0.9% saline causes hyperchloremic acidosis, renal vasoconstriction, and AKI 1. A propensity-matched study of 22,851 surgical patients showed hyperchloremia was present in ~20% and associated with increased 30-day mortality 1.

The SMART trial demonstrated that buffered crystalloids were associated with lower rates of major adverse kidney events (death, need for renal replacement therapy, persistent renal dysfunction) compared to 0.9% saline in critically ill patients 1, 2.

Common Pitfalls to Avoid

• Do not continue 0.9% saline "because the patient is stable" - hyperchloremia at 116 mEq/L already indicates harm and predicts worse outcomes 3
• Do not wait for severe acidosis to develop - the dose-response relationship shows mortality risk increases even at moderate elevations 3
• Do not assume hyperchloremia is benign - it independently increases mortality by 28% and AKI risk by 40% 3
• Do not use hypertonic saline for volume resuscitation - this will worsen hyperchloremia without mortality benefit 2

Monitoring Parameters

• Recheck chloride and electrolytes every 6-12 hours until normalized
• Monitor acid-base status with serial blood gases
• Assess renal function (creatinine, urine output) given the 40% increased AKI risk 3
• Watch for both extremes: hypochloremia (<98) also increases mortality by 55% 3

The non-linear relationship between chloride and mortality means both high and low values are harmful, so aim for normalization to 98-107 mEq/L 3.